About
Synosia Therapeutics develops small-molecule therapies aimed at treating neurological and psychiatric disorders, including drug candidates targeting Parkinson's disease.
Explore Synosia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.